Detalhe da pesquisa
1.
Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection.
PLoS Pathog
; 20(5): e1012205, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701094
2.
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2.
Nat Chem Biol
; 17(1): 113-121, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33082574
3.
How Mycobacterium tuberculosis builds a home: Single-cell analysis reveals M. tuberculosis ESX-1-mediated accumulation of anti-inflammatory macrophages in infected mouse lungs.
bioRxiv
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712150
4.
Mycobacterium tuberculosis resides in lysosome-poor monocyte-derived lung cells during chronic infection.
Res Sq
; 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37398178
5.
Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq.
Nat Commun
; 14(1): 6245, 2023 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37803001
6.
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling.
iScience
; 26(10): 107813, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37810211
7.
Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19.
Res Sq
; 2021 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34013247
8.
Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS.
Nat Commun
; 12(1): 5152, 2021 08 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34446707
9.
COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone.
Res Sq
; 2021 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469573
10.
Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19.
medRxiv
; 2021 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791731
11.
Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike.
bioRxiv
; 2020 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817948
12.
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.
Science
; 370(6523): 1473-1479, 2020 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33154106
13.
An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation.
bioRxiv
; 2020 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817938
14.
Treatment of Drug-Susceptible Tuberculosis.
Clin Chest Med
; 40(4): 763-774, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31731983